Learn about Legislative & Regulatory Infrastructure and how to successfully use Anti-Counterfeiting technologies to reduce costs and increase your business value

Für Pharmaunternehmen sind gefälschte Arzneimittel der Einnahmeverlust ein finanzielles Desaster. Unser vornehmlich englisch-sprachiger Kongress schafft eine Plattform für alle Beteiligten: von Aufsichtsbehörden, Europol bis zu Industrieexperten.

The production and trade of falsified medicines has become a growing worldwide illegal business.

The production and trade of falsified medicines has become a growing worldwide illegal business. Counterfeit medicines pose a public health risk because their content can be dangerous or they can lack active ingredients. Their use can result in treatment failure or even death. These products are channelled via internet pharmacies and increasingly through the legal supply chain. For pharmaceutical companies the loss of income and the liability for counterfeiting of brand products can be financially devastating. Strategies against counterfeited medicines become more important.

Corporate Security Anti-Counterfeiting Strategies

In February the European Parliament has adopted a new EU law on falsified medicines in an attempt to ensure that only high-quality medicines reach the legal supply chain. The new Directive introduces harmonized, pan-European safety measures and will touch all stakeholders concerned in the daily delivery of medicines.

Our conference will bring together regulatory authority representatives and industry experts to share experiences, to hear case studies and to learn from each other.

Sponsor	Media Partners